Research output per year
Research output per year
Search results
-
2024
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
Chien, K. S., Rodriguez-Sevilla, J. J., Alvarado, Y., Montalban-Bravo, G., Hammond, D. E., Swaminathan, M., Bazinet, A., Kimberley, J., Bodden, K., Schneider, H., Dong, X. Q., Pierce, S. A., Huang, X., Jabbour, E. J., Kantarjian, H. M. & Garcia-Manero, G., Dec 2024, In: Leukemia Research. 147, 107602.Research output: Contribution to journal › Letter › peer-review